Facioscapulohumeral Muscular Dystrophy
📧 Sign up to get email alerts when something new happens for Facioscapulohumeral Muscular Dystrophy.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-04-24Clinical Trial Update: Phase 1/2 Study of AOC 1020 in Participants With Facioscapulohumeral Muscular Dystrophy (FSHD) [Phase 1, Phase 2]
Phase 1/2 trial of AOC 1020 for facioscapulohumeral muscular dystrophy has completed enrollment; the update does not provide trial results.
-
CLINICAL_TRIALS trial_result · 2026-03-24Clinical Trial Update: Pro-inflammatory Cytokines in Facioscapulohumeral Muscular Dystrophy (CYTOKINE-FSH) [NA]
Completed study evaluating pro-inflammatory cytokines in facioscapulohumeral muscular dystrophy.
-
CLINICAL_TRIALS trial_result · 2026-02-27Clinical Trial Update: Quantitative Assessment of Orofacial Muscle Function in FSHD [NA]
This completed clinical trial from University of Mons evaluated quantitative measures of orofacial muscle function in individuals with facio…
-
CLINICAL_TRIALS trial_result · 2026-02-25Clinical Trial Update: Motor Outcomes to Validate Evaluations in Pediatric FSHD (MOVE Peds)
Clinical trial update for MOVE Peds, a pediatric study to validate motor outcome evaluations in facioscapulohumeral muscular dystrophy. The …
-
CLINICAL_TRIALS trial_result · 2026-01-09Clinical Trial Update: Ultrasound Detection of Early Facial Muscle Changes in FSHD: Thickness and Echo Intensity Findings
A completed clinical trial reports ultrasound-based detection of early facial muscle changes in facioscapulohumeral muscular dystrophy, deta…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-11-10Clinical Trial Update: Efficacy and Safety of Losmapimod in Treating Participants With Facioscapulohumeral Muscular Dystrophy (FSHD) (REACH) [Phase 3]
Phase 3 trial update for losmapimod in facioscapulohumeral muscular dystrophy (FSHD) indicates the study was terminated and results have bee…
-
CLINICAL_TRIALS trial_result · 2025-09-30Clinical Trial Update: Efficacy and Safety of Losmapimod in Treating Subjects With Facioscapulohumeral Muscular Dystrophy (FSHD) With Open-Label Extension (OLE) [Phase 2]
Phase 2 open-label extension study of losmapimod for facioscapulohumeral muscular dystrophy reports efficacy and safety results; the trial i…
-
CLINICAL_TRIALS trial_result · 2025-09-18Clinical Trial Update: FSHD Molecular Characterization
The clinical trial NCT06096441, studying molecular characterization of facioscapulohumeral muscular dystrophy, has been terminated.
-
CLINICAL_TRIALS trial_result · 2024-12-20Clinical Trial Update: Phase 2 Open-label Extension Study of AOC 1020 in Participants with Facioscapulohumeral Muscular Dystrophy (FSHD) [Phase 2]
Phase 2 open-label extension trial update for AOC 1020 in facioscapulohumeral muscular dystrophy (FSHD) by Avidity Biosciences; enrollment i…
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: The Risk of Falls Index for Patients With Neuromuscular Disorders
A completed trial evaluating a Falls Index to assess fall risk in patients with neuromuscular disorders, including Inclusion Body Myositis, …
-
CLINICAL_TRIALS trial_result · 2024-07-10Clinical Trial Update: Efficacy and Safety of Losmapimod in Subjects With Facioscapulohumeral Muscular Dystrophy (FSHD) [Phase 2]
Phase 2 results and safety data for Losmapimod in patients with Facioscapulohumeral Muscular Dystrophy have been posted after the study comp…
-
CLINICAL_TRIALS trial_result · 2023-12-22Clinical Trial Update: Study to Evaluate the Long-Term Safety, Tolerability, and Biological Activity of ATYR1940 in Participants With Limb Girdle and Facioscapulohumeral Muscular Dystrophy (FSHD) [Phase 1, Phase 2]
Phase 1/2 trial evaluating ATYR1940 for safety, tolerability, and biological activity in facioscapulohumeral muscular dystrophy and limb gir…
-
CLINICAL_TRIALS trial_result · 2023-10-19Clinical Trial Update: Evaluate Safety and Biological Activity of ATYR1940 in Participants With Early Onset Facioscapulohumeral Muscular Dystrophy [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating safety and biological activity of ATYR1940 in early-onset facioscapulohumeral muscular dystrophy (FSHD) …
-
CLINICAL_TRIALS trial_result · 2023-10-19Clinical Trial Update: Evaluate Safety and Biological Activity of ATYR1940 in Participants With Limb Girdle Muscular Dystrophy 2B (LGMD2B) and Facioscapulohumeral Muscular Dystrophy (FSHD) [Phase 1, Phase 2]
Phase 1/2 trial evaluating ATYR1940 for safety and biological activity in LGMD2B and FSHD has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2023-05-16Clinical Trial Update: Study of Testosterone and rHGH in FSHD [Phase 1]
Phase 1 clinical trial evaluating testosterone and recombinant human growth hormone in facioscapulohumeral muscular dystrophy has completed;…
-
CLINICAL_TRIALS trial_result · 2021-08-11Clinical Trial Update: Safety, Tolerability, Pharmacokinetics, and Biological Activity of ATYR1940 in Adult Participants With Muscular Dystrophy [Phase 1, Phase 2]
Phase 1/2 trial update for ATYR1940 in adults with facioscapulohumeral muscular dystrophy reports safety, tolerability, pharmacokinetics, an…
-
CLINICAL_TRIALS trial_result · 2021-06-02Clinical Trial Update: Extension Study to Evaluate the Long-Term Effects of ACE-083 in Patients With Facioscapulohumeral Muscular Dystrophy (FSHD) and Charcot-Marie Tooth (CMT) Disease Types 1 and X (CMT1 and CMTX) [Phase 2]
Phase 2 extension study evaluating long-term effects of ACE-083 in facioscapulohumeral muscular dystrophy (FSHD) and Charcot-Marie-Tooth dis…
-
CLINICAL_TRIALS trial_result · 2021-04-22Clinical Trial Update: Study of ACE-083 in Patients With Facioscapulohumeral Muscular Dystrophy (FSHD) [Phase 2]
Phase 2 trial of ACE-083 in facioscapulohumeral muscular dystrophy was terminated; results posted in 2021.
-
CLINICAL_TRIALS trial_result · 2019-11-05Clinical Trial Update: Bone Health in Facioscapulohumeral Muscular Dystrophy
Completed clinical trial on bone health in facioscapulohumeral muscular dystrophy; results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2017-10-11Clinical Trial Update: A Multicenter Collaborative Study on the Clinical Features, Expression Profiling, and Quality of Life of Infantile Onset FSHD
A completed multicenter study of infantile-onset facioscapulohumeral muscular dystrophy examining clinical features, expression profiling, a…
-
CLINICAL_TRIALS trial_result · 2016-04-25Clinical Trial Update: High Intensity Training in Patients With Facioscapulohumeral Muscular Dystrophy [NA]
This document provides an update on a completed clinical trial evaluating high-intensity training in patients with facioscapulohumeral muscu…
-
CLINICAL_TRIALS trial_result · 2015-12-09Clinical Trial Update: Prospective Study for 24-months of Physical Training Introduced in Lifestyle of Patients With FSHD : Tolerance, Sustainability and Efficiency of Unsupervised Training Program.
Completed prospective study evaluating a 24-month unsupervised physical training program for patients with facioscapulohumeral muscular dyst…
-
CLINICAL_TRIALS trial_result · 2015-07-28Clinical Trial Update: Study of Morphology and Functional Magnetic Resonance Imaging (MRI) Muscle Patients With Muscular Dystrophy Type FSHD Benefiting a Physical Training Introduced.
A completed clinical trial evaluating morphology and functional MRI in patients with facioscapulohumeral muscular dystrophy undergoing a phy…
-
CLINICAL_TRIALS trial_result · 2015-05-14Clinical Trial Update: 1 Year MRI Followup in Facioscapulohumeral Muscular Dystrophy
This update reports on a completed clinical trial evaluating 1-year MRI follow-up in patients with Facioscapulohumeral muscular dystrophy (F…
-
CLINICAL_TRIALS trial_result · 2015-04-01Clinical Trial Update: Physical Training Introduction in Lifestyle of Facioscapulohumeral Dystrophy Patients [NA]
This clinical trial update reports the completion of a study evaluating the introduction of physical training in the lifestyle management of…